Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume 14, Issue 1, Pages 391-405
Publisher
Wiley
Online
2022-12-13
DOI
10.1002/jcsm.13141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exercise in the heat induces similar elevations in serum irisin in young and older men despite lower resting irisin concentrations in older adults
- (2022) James J. McCormick et al. JOURNAL OF THERMAL BIOLOGY
- FNDC5/Irisin: Physiology and Pathophysiology
- (2022) Rashid Waseem et al. MOLECULES
- Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
- (2021) Roberta Sartori et al. Nature Communications
- Combination Usage of AdipoCount and Image-Pro Plus/ImageJ Software for Quantification of Adipocyte Sizes
- (2021) Yepeng Hu et al. Frontiers in Endocrinology
- Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
- (2021) Ming-Yun Ho et al. Cells
- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle : update 2021
- (2021) Stephan Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit
- (2020) Sean L. McGee et al. Nature Reviews Endocrinology
- Fndc5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice
- (2019) Yan Xiong et al. FASEB JOURNAL
- Nanotechnology‐Mediated Drug Delivery for the Treatment of Obesity and Its Related Comorbidities
- (2019) Yung‐Hao Tsou et al. Advanced Healthcare Materials
- FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
- (2019) Xin Zhang et al. CELL DEATH AND DIFFERENTIATION
- Sarcopenia
- (2019) Alfonso J Cruz-Jentoft et al. LANCET
- From discoveries in ageing research to therapeutics for healthy ageing
- (2019) Judith Campisi et al. NATURE
- Treatment of type 2 diabetes with the designer cytokine IC7Fc
- (2019) Maria Findeisen et al. NATURE
- Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors
- (2018) Hyeonwoo Kim et al. CELL
- Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models
- (2018) Mychael V. Lourenco et al. NATURE MEDICINE
- Quantitative analysis of histopathological findings using image processing software
- (2017) Yasushi Horai et al. Journal of Toxicologic Pathology
- Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys
- (2017) Hui Peng et al. Nature Communications
- Irisin is a pro-myogenic factor that induces skeletal muscle hypertrophy and rescues denervation-induced atrophy
- (2017) Musarrat Maisha Reza et al. Nature Communications
- miR-29b contributes to multiple types of muscle atrophy
- (2017) Jin Li et al. Nature Communications
- Irisin treatment improves healing of dystrophic skeletal muscle
- (2017) Musarrat Maisha Reza et al. Oncotarget
- Skeletal muscle performance and ageing
- (2017) Michael Tieland et al. Journal of Cachexia Sarcopenia and Muscle
- Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice
- (2017) Graziana Colaianni et al. Scientific Reports
- A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects
- (2016) Saswata Talukdar et al. Cell Metabolism
- Harnessing Fc receptor biology in the design of therapeutic antibodies
- (2016) Peter Sondermann et al. CURRENT OPINION IN IMMUNOLOGY
- GLP-1-Exendin-4/IgG4 (Fc) Fusion Protein as a Novel Drug for Diabetes Treatment
- (2015) Y. Gan et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice
- (2015) Young Mee Yoon et al. Scientific Reports
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study
- (2013) Ho Cheol Hong et al. HEPATOLOGY
- Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
- (2013) Hui-Jie Zhang et al. JOURNAL OF HEPATOLOGY
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future
- (2011) S. Madsbad et al. DIABETES OBESITY & METABOLISM
- Impact of albumin on drug delivery — New applications on the horizon
- (2011) Bakheet Elsadek et al. JOURNAL OF CONTROLLED RELEASE
- Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
- (2010) Wolfgang Glaesner et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Optimization of Fc-mediated effector functions of monoclonal antibodies
- (2009) William R Strohl CURRENT OPINION IN BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now